Cell Therapy Manufacturing: The Supply Chain Challenge

The success of cell therapies hinges on not only proving that a product elicits the desired biological response, but also overcoming the challenges of manufacturing and administering a complex product to any patient.

For Up-to-$825M, Daiichi Sankyo Joins AstraZeneca in Co-Marketing Movantik

Deal signed less than a month before the planned launch of the opioid-induced constipation (OIC) treatment for adults with chronic non-cancer pain.

HIV Transmission Blocked by Often Overlooked Class of Antibody

A group of scientists at Texas Biomedical Research Institute have zeroed in on a new defense against HIV-1, the virus that causes AIDS.

Sanofi, Evotec Launch New “BRIDGE” Partnership to Accelerate Drug Discovery

Evotec said today it will join Sanofi in partnering with academic institutions to translate their research into new small-molecule drugs across multiple unspecified therapeutic...

Cancer’s Grip May Be Loosened by Tampering with DNA Clamp

A rationally designed drug-like protein interferes with the protein-protein interactions of PCNA, the so-called DNA clamp, offering a new way of hindering DNA replication in fast-proliferating cancer cells.

Otsuka to Acquire Visterra for $430M, Adding to Its Pipeline and...

Through the acquisition, Otsuka will inherit Visterra’s Hierotope® platform, intended to design and engineer precision antibody-based therapies, and expand its pipeline with Visterra’s programs targeting infectious diseases, kidney diseases, cancer, and chronic pain.

Immunocompromised Patients Could Get Help from New Vaccine Strategy

Bolstering the immune system is not a new strategy when trying to protect against deadly pathogens, yet for those individuals that are immunocompromised, this...

HIV Biologic Drug Reduces Viral Load While Boosting Immunity

A new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV infection.

Lyme, Seven Other Tick-Borne Diseases Detected with New Serochip

A serochip-based blood test with multiplex capabilities has been designed to detect Lyme disease and/or one of seven other tick-borne diseases

Antiviral Therapies Shown to Be Effective against Multiple Viruses

Team says research results show existing safe-in-human broad-spectrum antivirals could be used on other viral infections.

Recently Featured

Scroll Up